UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

PloS one, 2009-03, Vol.4 (3), p.e4724-e4724

2009

Volltextzugriff (PDF)

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

Journal of virology, 2016-07, Vol.90 (13), p.6058-6070

2016

Volltextzugriff (PDF)

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

PloS one, 2012-07, Vol.7 (7), p.e40514-e40514

2012

Volltextzugriff (PDF)

In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis

PloS one, 2013-04, Vol.8 (4), p.e61102

2013

Volltextzugriff (PDF)

Recommendations on data sharing in HIV drug resistance research

PLoS medicine, 2023-09, Vol.20 (9), p.e1004293-e1004293

2023

Volltextzugriff (PDF)

Emerging SARS-CoV-2 Resistance After Antiviral Treatment

JAMA network open, 2024-09, Vol.7 (9), p.e2435431

2024

Volltextzugriff (PDF)

Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study

Brain (London, England : 1878), 2024-08, Vol.147 (8), p.2652-2667

2024

Volltextzugriff (PDF)

A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors

The Journal of clinical investigation, 1998-11, Vol.102 (10), p.1769-1775

1998

Volltextzugriff (PDF)

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

Annals of internal medicine, 1998-06, Vol.128 (11), p.906

1998

Volltextzugriff (PDF)

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

EBioMedicine, 2017-04, Vol.18 (C), p.225-235

2017

Volltextzugriff (PDF)

Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years

Antimicrobial Agents and Chemotherapy, 1997-04, Vol.41 (4), p.757-762

1997

Volltextzugriff (PDF)

Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations

AIDS (London), 2005-04, Vol.19 (7), p.731-733

2005

Volltextzugriff (PDF)

Biomarker discovery using targeted maximum-likelihood estimation: Application to the treatment of antiretroviral-resistant HIV infection

Statistics in medicine, 2009-01, Vol.28 (1), p.152-172

2009

Volltextzugriff (PDF)

Accuracy, Precision, and Consistency of Expert HIV Type 1 Genotype Interpretation: An International Comparison (The GUESS Study)

Clinical infectious diseases, 2005-07, Vol.41 (1), p.92-99

2005

Volltextzugriff (PDF)

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations

The Journal of infectious diseases, 1994-04, Vol.169 (4), p.722-729

1994

Volltextzugriff (PDF)

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy

Journal of acquired immune deficiency syndromes (1999), 2001-08, Vol.27 (4), p.377-380

2001

Volltextzugriff (PDF)

Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients

Journal of acquired immune deficiency syndromes (1999), 2002-10, Vol.31 (2), p.121-127

2002

Volltextzugriff (PDF)

Sensitivity of HIV-1 Reverse Transcriptase and Its Mutants to Inhibition by Azidothymidine Triphosphate

Biochemistry (Easton), 1994-03, Vol.33 (8), p.2113-2120

1994

Volltextzugriff (PDF)

Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors

Antimicrobial Agents and Chemotherapy, 1996-12, Vol.40 (12), p.2887-2890

1996

Volltextzugriff (PDF)

Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy

Annals of internal medicine, 1994-08, Vol.121 (4), p.263

1994

Volltextzugriff (PDF)

Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

Journal of virological methods, 2000-05, Vol.86 (2), p.143-153

2000

Volltextzugriff (PDF)

HIV-1 syncytium-inducing phenotype, virus burden codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients

Journal of acquired immune deficiency syndromes (1988), 1994-08, Vol.7 (8), p.832-838

1994

Volltextzugriff (PDF)

Zidovudine Resistance Reverse Transcriptase Mutations during Didanosine Monotherapy

The Journal of infectious diseases, 1996-08, Vol.174 (2), p.448-449

1996

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaMutation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis

Recommendations on data sharing in HIV drug resistance research

Emerging SARS-CoV-2 Resistance After Antiviral Treatment

Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study

A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years

Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations

Biomarker discovery using targeted maximum-likelihood estimation: Application to the treatment of antiretroviral-resistant HIV infection

Accuracy, Precision, and Consistency of Expert HIV Type 1 Genotype Interpretation: An International Comparison (The GUESS Study)

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy

Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients

Sensitivity of HIV-1 Reverse Transcriptase and Its Mutants to Inhibition by Azidothymidine Triphosphate

Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors

Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy

Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

HIV-1 syncytium-inducing phenotype, virus burden codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients

Zidovudine Resistance Reverse Transcriptase Mutations during Didanosine Monotherapy

Aktive Filter

Suchergebnisse filtern